- Inovio Pharmaceuticals (NASDAQ:INO) has added Kaneka Eurogentec S.A. to the consortium of companies that will manufacture COVID-19 vaccine candidate INO-4800.
- Kaneka joins Thermo Fisher Scientific, Richter-Helm BioLogics and Ology Biosciences.
- Financial terms are not disclosed.
- The first segment of a Phase 2/3 clinical trial, INNOVATE, is ongoing.
- https://seekingalpha.com/news/3641335-inovio-adds-new-member-to-manufacturing-group-for-covidminus-19-vaccine
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.